FP-014

· Foresee Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FP-014, covering 2025-04-27 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer [Phase 3]